The Endoscopic Vessel Harvesting Systems Market was valued at USD 0.51 billion in 2023. The Endoscopic Vessel Harvesting Systems Market industry is projected to grow from USD 0.53 billion in 2024 to USD 0.70 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 4.00% during the forecast period (2024 - 2032).
The increasing rates of cardiovascular illnesses and rising preference for minimally invasive surgery are the primary market drivers propelling the market's expansion.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
HEMOPRO technology with cutting and sealing to ensure optimal lumen quality during coronary artery bypass graft (CABG) surgery and less thermal effect was introduced in June 2023 when MAQUET Cardiovascular unveiled the VASOVIEW HEMOPRO 2 Endoscopic Vessel Harvesting (EVH) System. An example is the existence of another minimally invasive system which is known as VASOVIEW HEMOPRO 2.
In May 2021, PENTAX Medical, a subsidiary of HOYA Group, and Jiangsu Vedkang Medical Science and Technology Co., Ltd. announced the formation of PENTAX Medical Therapeutics (Jiangsu) Co., Ltd., aimed at developing single-use therapeutic products for flexible medical endoscopy market.
In January 2022, Getinge enrolled its EVH Circle of Excellence with some of the most committed clinicians conducting endoscopic vessel harvesting (EVH) procedures.
Getinge included some of the most dedicated clinicians performing EVH procedures in North America within their EVH Circle of Excellence.
LivaNova claimed that its Memo 4D semi-rigid mitral annuloplasty ring has been approved by the FDA to treat mitral regurgitation in 2021 while still compatible with LivaNova's Cineflex Ultraflexible endoscopic vessel harvesting system for more conservative cardiac surgeries.
FDA approved Saphena Medical’s Venapax endoscopic vessel harvesting system for use on patients undergoing coronary artery bypass grafting procedures who require saphenous vein harvests in 2020.
In 2020, Terumo Cardiovascular Systems Corporation released VirtuoSaph Plus for use as an endoscopic vascular harvesting device intended to enable surgeons to see clearly during operations as well as improve the efficacy and safety of the vessel harvesting process.
In 2020, MAQUET Holding B.V. & Co. KG (Getinge Group) revealed that its VASOVIEW 8 endoscopic vessel harvesting system had just got FDA approval; this new version is distinguished by ergonomic design and advanced imaging technology used in order to provide more precise vessel harvesting.
Plaque accumulation is often the cause of coronary artery disease (CAD), which is a narrowing or blockage of the coronary arteries. The rising number of senior citizens and the prevalence of coronary artery disease (CAD) are driving the market CAGR. Additionally, as per an article distributed by PubMed Central in July 2022, coronary vein sickness, also called coronary illness, is much of the time brought about by diminished myocardial perfusion that causes infections like angina, myocardial dead tissue (MI), and cardiovascular breakdown, among others, and accounts for one-third to one-half of all cardiovascular illness.
Thus, because of the great burden of coronary artery infection, the concentrated section is supposed to encounter development during the conjecture time of the study. Moreover, as per an article checked by Healthdirect Australia in June 2022, coronary illness is the most well-known reason for death in Australia, and a few risk factors for this incorporate smoking, excessive alcohol utilization, absence of activity, social disengagement, and being overweight or obese.
Subsequently, the high weight of CAD in different nations is supposed to help the adoption of endoscopic vessel gathering methodology for its treatment.
Additionally, the expanded risk of CAD with the increasing age and the rising geriatric populace overall are other main considerations driving the segment's development. For example, as per an article updated by NCBI in November 2022, the frequency of CAD rises with age, regardless of gender. Also, the rising investment in CAD research is predicted to raise progressed endoscopic vessel harvesting methodology on the market.
The high-level clinical imaging innovation in the EVH gadgets empowered the specialists with further developed visualization abilities. For example, the integration of near-infrared fluorescence imaging in EVH gadgets considers constant visualization of blood vessels during the harvesting system, improving accuracy and diminishing the risk of harm to the vessels. The progression of EVH gadgets guarantees improved results in coronary artery bypass grafting (CABG) methods, which support market growth. Thus driving the Endoscopic Vessel Harvesting Systems market revenue.
Based on Product, the Endoscopic Vessel Harvesting Systems Market segmentation includes EVH systems, endoscopes, and accessories. In 2023, the EVH systems segment dominated the market. The clinical necessity for minimally invasive methods in cardiac surgery, especially for operations like coronary artery bypass grafting (CABG), is what drives the demand for EVH devices. A crucial part of CABG surgery is endoscopic vascular harvesting, and EVH devices provide more benefits than open harvesting techniques. It is projected that this clinical necessity will increase demand for EVH systems in the context of cardiac surgery.
The endoscope category is anticipated to be the fastest growing. Endoscopes, which give top-quality vision of blood, allow specialists to precisely identify and assess the quality of blood vessels for harvesting. This visualization is important for vascular grafting treatment to find lasting success.
Figure 1: Endoscopic Vessel Harvesting Systems Market, by Product, 2023 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Based on Usability, the Endoscopic Vessel Harvesting Systems Market segmentation includes reusable and disposable. In 2023, the reusable category generated the most income. Reusable EVH systems are usually less expensive since they can be cleaned and used repeatedly. Reusable systems may be more affordable in the long run for healthcare institutions with high procedure volumes, which would increase demand for this market. Additionally, healthcare institutions can select appropriate instruments and accessories with reusable EVH systems because of their increased flexibility and customization choices. Because of its adaptability, the vessel harvesting process may be optimized and made more efficient, which increases demand for reusable systems.
The Endoscopic Vessel Harvesting Systems’ disposable segment market is anticipated to grow fastest during the forecast period. During surgical operations, endoscopes are covered and shielded by endoscope sheaths. In order to lower the danger of infection and avoid cross-contamination between patients, disposable sheaths are made to be used just once.
Based on Application, the Endoscopic Vessel Harvesting Systems Market segmentation includes coronary artery disease (CAD) and peripheral artery disease (PAD). The coronary artery disease (CAD) category leads the market. Better CAD detection, diagnosis, and treatment are the result of more healthcare spending and easier access to healthcare. Modern diagnostic methods and medical technology allow for early identification of CAD, which facilitates prompt therapies to stop the disease's progression and lessen its consequences.
Furthermore, CAD is one of the world's top causes of mortality and has been increasing as a result of several lifestyle-related issues. Due to the increased risk of developing CAD with age, the aging population, in particular, raises the prevalence of the illness. It fuels the growing need for endoscopic vessel harvesting devices for CAD applications.
The Endoscopic Vessel Harvesting Systems market’s peripheral artery disease (PAD) segment is anticipated to grow fastest during the projection period. EVH devices allow vein harvesting for vascular bypass surgeries in patients with PAD in a less invasive manner. Endoscopic vessel harvesting is a beneficial choice for individuals with PAD who may have compromised health owing to underlying cardiovascular diseases since it minimizes surgical stress, postoperative discomfort, and recovery time when compared to standard open harvesting approaches.
By region, the study provides market insights into North America, Europe, Asia-Pacific, and the Rest of the World. The North American Endoscopic Vessel Harvesting Systems market will dominate this market. North America has a huge burden of cardiovascular disorders (CVDs), including coronary artery sickness (CAD) and peripheral artery illness. Thus, there is a significant interest in successful treatment choices, including CABG medical procedures where endoscopic vessel harvesting frameworks are used.
Furthermore, the need for these systems in the area is fueled by ongoing developments in endoscopic vessel harvesting systems, such as the creation of less invasive methods and robotically assisted operations.
Further, the major countries studied in the market report are the US, Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 2: Endoscopic Vessel Harvesting Systems Market Share By Region 2023 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe's Endoscopic Vessel Harvesting Systems market accounts for the second-largest market share. Europe boasts advanced medical services infrastructure, including modern clinics and surgical facilities equipped with the most recent medical innovations. This system works with the adoption of cutting-edge surgical strategies like endoscopic vessel harvesting. Further, the German Endoscopic Vessel Harvesting Systems market held the largest market share, and the UK Endoscopic Vessel Harvesting Systems market was the fastest-growing market in the European region.
The Asia-Pacific Endoscopic Vessel Harvesting Systems Market is expected to grow at the fastest CAGR from 2024 to 2032. Countries in the Asia Pacific area are expanding their medical services Investment to develop further medical services framework, access to clinical benefits, and patient results. This investment creates an atmosphere that is conducive to the use of cutting-edge medical technology like endoscopic vessel harvesting systems. Moreover, China’s Endoscopic Vessel Harvesting Systems market held the largest market share, and the Indian Endoscopic Vessel Harvesting Systems market was the fastest-growing market in the Asia-Pacific region.
The industry's leading players will keep investing heavily in R&D to expand their product lines, which will propel the Endoscopic Vessel Harvesting Systems market's growth. Contractual agreements, mergers and acquisitions, increased investments, collaboration with other companies, and the production of new products are examples of significant market developments. To increase their worldwide reach, market players also take part in a variety of strategic initiatives. In order to survive and expand in a more competitive and dynamic market, the Endoscopic Vessel Harvesting Systems industry must offer reasonably priced products and services.
One of the main strategies manufacturers use in the worldwide Endoscopic Vessel Harvesting Systems market is local manufacturing, which expands the market sector and helps customers by lowering running expenses. In recent years, some of the largest medicinal advantages have come from the Endoscopic Vessel Harvesting Systems sector. Major players in the Endoscopic Vessel Harvesting Systems market, including Getinge AB, Cardio Precision Ltd., Terumo Corporation, KARL STORZ SE & Co. KG, Livanova PLC, Medical Instruments Spa, and Saphena Medical, and others, are making investments in R&D activities in an effort to boost market demand.
Terumo Corp (Terumo) makes and markets clinical consideration items, including emergency clinic items, clinical items, and hardware. The organization's significant item classes incorporate drugs, blood packs, dispensable clinical gadgets, nourishing food supplements, cardiovascular frameworks, vascular grafts, blood glucose monitoring systems, medical electronics, peritoneal dialysis, and advanced thermometers. Its systems find applications in treatments performed inside blood vessels and vascular medical procedures. Terumo likewise works in blood centers to collect blood and handle it to address the necessity of transfusion in patients. In September 2022, Terumo Cardiovascular established its newest production facility in Cartago, Costa Rica's La Lima.
A MedTech business called CardioPrecision creates devices and technologies for the minimally invasive treatment of structural heart disease. The company's main focus was on the novel transcervical technique for minimally invasive aortic valve procedures and surgery. It enables medical professionals to carry out minimally invasive treatments using a tiny neck incision.
Both transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR) have been effectively performed using the company's CoreVista® devices. Similar advantages for patients and healthcare professionals are anticipated for other cardiovascular applications, such as TMVR, TEVAR, EVAR, and LVAD implantation. Less discomfort and a quicker recovery are two main advantages.
Reduced chance of infection and transfusion, as well as less blood loss and a much shorter hospital stay, are possible secondary advantages. CardioPrecision presented their CoreVista gadget suite in September 2021 for use in endoscopic vessel harvesting (EVH) during coronary artery bypass grafting (CABG) activities.
January 2022: Getinge named the Getinge EVH Circle of Excellence in honor of some of the most committed medical professionals in North America who undertake endoscopic vascular harvesting (EVH) treatments.
January 2021: Venapax is a unitary endoscopic vessel harvesting device manufactured by Saphena Medical. Premier's highly dedicated SURPASS (Synergizing for Unparalleled Results in Procurement and Strategic Sourcing) initiative awarded Saphena Medical a contract in the EVH category. One of the biggest performance enhancement firms in the United States is Premier Inc.
| Report Attribute/Metric | Details |
| Market Size 2023 | USD 0.51 Billion |
| Market Size 2024 | USD 0.53 Billion |
| Market Size 2032 | USD 0.70 Billion |
| Compound Annual Growth Rate (CAGR) | 4.00% (2024-2032) |
| Base Year | 2023 |
| Market Forecast Period | 2024-2032 |
| Historical Data | 2019-2022 |
| Market Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Product, Usability, Application, and Region |
| Geographies Covered | North America, Europe, Asia Pacific, and the Rest of the World |
| Countries Covered | The US, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
| Key Companies Profiled | Getinge AB, Cardio Precision Ltd., Terumo Corporation, KARL STORZ SE & Co. KG, Livanova PLC, Medical Instruments Spa, and Saphena Medical |
| Key Market Opportunities | · The increasing adoption of telemedicine platforms and remote surgery and the expansion of indications beyond CABG procedures |
| Key Market Dynamics | · Rising prevalence of cardiovascular diseases and growing preference for minimally invasive surgery |
Frequently Asked Questions (FAQ) :
The Endoscopic Vessel Harvesting Systems Market size was valued at USD 0.51 Billion in 2023.
The global market is projected to grow at a CAGR of 4.00% during the forecast period, 2024-2032.
North America had the largest share of the global market
The key players in the market are Getinge AB, Cardio Precision Ltd., Terumo Corporation, KARL STORZ SE & Co. KG, Livanova PLC, Medical Instruments Spa, and Saphena Medical.
The EVH Systems category dominated the market in 2023.
Reusable had the largest share in the global market.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
